Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ChemPacific is a global contract development and manufacturing organization (CDMO) that provides a wide range of services to the pharmaceutical and biotechnology industries. Founded in 1994, the company specializes in the custom synthesis of complex small molecules, medicinal chemistry, and process research and development. ChemPacific operates facilities in both the United States and China, offering a seamless transition from laboratory-scale R&D to large-scale GMP manufacturing of active pharmaceutical ingredients (APIs) and intermediates. Their expertise includes multi-step synthesis, chiral chemistry, and the production of high-potency compounds. The company supports clients through all stages of drug development, from initial discovery to commercial supply.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 1ChemPacific Corp.